Galcanezumab Beats Placebo for Episodic Migraine

THURSDAY, May 31, 2018 -- For patients with episodic migraine, galcanezumab is better than placebo for reducing migraine headache days, according to a study published online May 29 in JAMA Neurology. Virginia L. Stauffer, Pharm.D., from Eli Lilly...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news